Immtech Announces Results From Hepatitis C Discovery Program
Jun 10th 2008Drug InformationLiver Disease / Hepatitis
Immtech Pharmaceuticals, Inc. (Amex: IMM) announced positive results against the hepatitis C virus (HCV) of a compound from its drug discovery portfolio. The prototype compound belongs to an expanding class of compounds that has previously demonstrated activity against a related surrogate virus, bovine viral diarrhea virus (BVDV).
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
